Palmitoylcarnitine

Palmitoylcarnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 1026 references associated with Palmitoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Palmitoylcarnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Palmitoylcarnitine

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Insulin Resistance D007333 99 associated lipids
Mitochondrial Diseases D028361 25 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Palmitoylcarnitine

Download all related citations
Per page 10 20 50 100 | Total 302
Authors Title Published Journal PubMed Link
pmid:6305529
Gohil K et al. Fatty acid oxidation in mitochondria from needle biopsy samples of human skeletal muscle. 1984 Clin. Sci. pmid:6319070
Nakaki T et al. Inhibition by palmitoylcarnitine of adhesion and morphological changes in HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate. 1984 Cancer Res. pmid:6324991
pmid:6325716
pmid:6329291
Paulson DJ and Shug AL Inhibition of the adenine nucleotide translocator by matrix-localized palmityl-CoA in rat heart mitochondria. 1984 Biochim. Biophys. Acta pmid:6331504
Kuo TH et al. Defective oxidative metabolism of heart mitochondria from genetically diabetic mice. 1983 Diabetes pmid:6414861
Murthy MS and Pande SV Mechanism of carnitine acylcarnitine translocase-catalyzed import of acylcarnitines into mitochondria. 1984 J. Biol. Chem. pmid:6430896
Kesterson JW et al. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. 1984 Nov-Dec Hepatology pmid:6437960
pmid:6498215
Kanter P et al. Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms. 1984 Biochem. Biophys. Res. Commun. pmid:6608349
pmid:6631531
Gross RW et al. Rabbit myocardial lysophospholipase-transacylase. Purification, characterization, and inhibition by endogenous cardiac amphiphiles. 1983 J. Biol. Chem. pmid:6654912
Fishlock RC et al. Sources of error in determinations of carnitine and acylcarnitine in plasma. 1984 Clin. Chem. pmid:6692545
pmid:6703040
Ballantyne JS and Storey KB Mitochondria from the hepatopancreas of the marine clam Mercenaria mercenaria: substrate preferences and salt and pH effects on the oxidation of palmitoyl-L-carnitine and succinate. 1984 J. Exp. Zool. pmid:6736891
pmid:6804748
Gross RW and Sobel BE Rabbit myocardial cytosolic lysophospholipase. Purification, characterization, and competitive inhibition by L-palmitoyl carnitine. 1983 J. Biol. Chem. pmid:6833297
Wise BC and Kuo JF Modes of inhibition by acylcarnitines, adriamycin and trifluoperazine of cardiac phospholipid-sensitive calcium-dependent protein kinase. 1983 Biochem. Pharmacol. pmid:6847716
Katoh N et al. Substrate proteins for calmodulin-sensitive and phospholipid-sensitive Ca2+-dependent protein kinases in heart, and inhibition of their phosphorylation by palmitoylcarnitine. 1981 Proc. Natl. Acad. Sci. U.S.A. pmid:6946429